Answer
No. Nivolumab is an immune checkpoint inhibitor that strengthens T-cell responses against cancer; it may be used alone or alongside chemotherapy or other anticancer treatments.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- OPDIVO 600 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.